The Domino Effect: 2025 Trends in Specialty Drug Benefits Report
カートのアイテムが多すぎます
カートに追加できませんでした。
ウィッシュリストに追加できませんでした。
ほしい物リストの削除に失敗しました。
ポッドキャストのフォローに失敗しました
ポッドキャストのフォロー解除に失敗しました
The Domino Effect: 2025 Trends in Specialty Drug Benefits Report
-
ナレーター：
-
著者：
このコンテンツについて
Specialty drug benefit design isn't just one decision — it triggers a domino effect impacting employer and health plan costs, patient access, care delivery and patient cost-sharing. In this episode, we unpack PSG’s latest research on how employers and health plans are rethinking specialty strategies amid rising pressure: cost management as a top priority, movement toward rebate alternatives, shifting site of care models, and evolving approaches to affordability and utilization management. Our guests break down where the biggest shifts are happening, what’s still missing, and how smarter benefit design can create better outcomes across the healthcare system.
- PSG (Pharmaceutical Strategies Group)
- 2025 Trends in Specialty Drug Benefits Report
- Specialty Drugs
- Drug Utilization
- PBM (Pharmacy Benefit Manager)
- Copay Assistance (Maximizers & Accumulators)
- Drug Rebates
- Drug “Carve Outs”
- Value-Based Agreements
- Utilization Management
- Step Therapy
- Biosimilars
- Site-of-Care
Questions or comments?
Email us at comments@prescriptionforbetteraccess.com.
Find us on social media! Follow us on X, LinkedIn, YouTube and Threads.